- Home
- LAES vs ESPR Comparison
LAES vs ESPR Comparison
Compare LAES & ESPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LAES
- ESPR
- Stock Information
- Founded
- LAES 2022
- ESPR 2008
- Country
- LAES Switzerland
- ESPR United States
- Employees
- LAES N/A
- ESPR N/A
- Industry
- LAES Semiconductors
- ESPR Biotechnology: Pharmaceutical Preparations
- Sector
- LAES Technology
- ESPR Health Care
- Exchange
- LAES Nasdaq
- ESPR Nasdaq
- Market Cap
- LAES 307.1M
- ESPR 305.0M
- IPO Year
- LAES N/A
- ESPR 2013
- Fundamental
- Price
- LAES $3.77
- ESPR $1.54
- Analyst Decision
- LAES Strong Buy
- ESPR Buy
- Analyst Count
- LAES 1
- ESPR 7
- Target Price
- LAES $6.00
- ESPR $6.36
- AVG Volume (30 Days)
- LAES 14.3M
- ESPR 4.0M
- Earning Date
- LAES 03-24-2025
- ESPR 03-04-2025
- Dividend Yield
- LAES N/A
- ESPR N/A
- EPS Growth
- LAES N/A
- ESPR N/A
- EPS
- LAES N/A
- ESPR N/A
- Revenue
- LAES $20,135,000.00
- ESPR $332,314,000.00
- Revenue This Year
- LAES N/A
- ESPR $5.51
- Revenue Next Year
- LAES N/A
- ESPR $1.42
- P/E Ratio
- LAES N/A
- ESPR N/A
- Revenue Growth
- LAES N/A
- ESPR 185.66
- 52 Week Low
- LAES $0.29
- ESPR $1.47
- 52 Week High
- LAES $11.00
- ESPR $3.94
- Technical
- Relative Strength Index (RSI)
- LAES 56.35
- ESPR 34.95
- Support Level
- LAES $2.40
- ESPR $1.47
- Resistance Level
- LAES $2.94
- ESPR $1.61
- Average True Range (ATR)
- LAES 0.38
- ESPR 0.13
- MACD
- LAES 0.11
- ESPR -0.01
- Stochastic Oscillator
- LAES 84.75
- ESPR 7.69
About LAES SEALSQ Corp
SEALSQ Corp develops certified secure microcontrollers and implements post-quantum cryptography. The company develops solutions including post-quantum microchips and devices that can be used in a variety of applications, from multi-factor authentication, home automation, and IT network infrastructure to automotive, industrial automation, and control systems. Its vaultIC range offers a complete set of ready-to-use secure elements designed to implement embedded security for any kind of device with fast time-to-market and high flexibility. The company's products include VaultIC155, VaultIV18x, VaultIC292, and VaultIC40x. The company generates a majority of its revenue from North America.
About ESPR Esperion Therapeutics Inc.
Esperion Therapeutics Inc is a pharmaceutical company. It specializes in developing and commercializing accessible, oral, once-daily, non-statin medicines for patients struggling with elevated low-density lipoprotein cholesterol. The firm has the business of researching, developing and commercializing therapies for the treatment of patients with the elevated low-density lipoprotein cholesterol operating segment. Its products include NEXLETOL, NEXLIZET, NILEMDO and NUSTENDI. The Company manages its business in one operating segment, which is the business of researching, developing and commercializing therapies for the treatment of patients with elevated LDL-C.